Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126014941 | 12601494 | 1 | I | 20160713 | 0 | 20160727 | 20160727 | DIR | 18.00 | YR | M | N | 170.00000 | LBS | 20160726 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126014941 | 12601494 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | Y | D | 20170702 | 0 | 2 | DF | COATED TABLET | HS | ||||
126014941 | 12601494 | 3 | C | OMEGA-3 FA | 2 | 0 | |||||||||||||
126014941 | 12601494 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
126014941 | 12601494 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
126014941 | 12601494 | 9 | C | MVI | VITAMINS | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126014941 | 12601494 | 1 | Schizophrenia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126014941 | 12601494 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126014941 | 12601494 | Anxiety | |
126014941 | 12601494 | Homicidal ideation | |
126014941 | 12601494 | Paranoia | |
126014941 | 12601494 | Psychotic disorder | |
126014941 | 12601494 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126014941 | 12601494 | 1 | 14 | DAY |